Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Holding(s) in Company

2 Nov 2016 12:57

RNS Number : 1560O
Midatech Pharma PLC
02 November 2016
ย 

ย 

ย 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

ย 

Midatech Pharma Plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

ย 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

ย 

ย 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

ย 

An event changing the breakdown of voting rights

Yes

ย 

Other (please specify):

ย 

Placing and open offer

3. Full name of person(s) subject to thenotification obligation:

ย 

Legal & General Group Plc (Group)

ย 

Legal & General Investment Management Limited (LGIM)

ย 

4. Full name of shareholder(s) ย (if different from 3.):

Legal & General Assurance Society Limited (LGAS & LGPL)

ย 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

ย 

31 October 2016

6. Date on which issuer notified:

02 November 2016

7. Threshold(s) that is/are crossed orreached:

ย 

LGIM (Above 5%), L&G (From 3% to 5%)

ย 

8. Notified details:

ย 

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

ย 

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct

Indirect

ORD GBP 0.00005

ย 

1,043,500

(L&G)

ย 

ย 4,290,518

ย 2,472,018

ย 1,818,500

5.07%

3.73%

ย First notification under DTR Sourcebook

(LGIM)

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

ย 

Type of financialinstrument

ย 

Expirationdate

ย 

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

ย 

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

ย 

Type of financialinstrument

ย 

ย 

Exercise price

ย 

Expiration date

ย 

Exercise/Conversion period

ย 

Number of voting rights instrument refers to

ย 

ย 

% of voting rights

ย 

ย 

ย 

Nominal

Delta

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

ย 

ย 2,472,018

(L&G)

ย 

5.07%

ย 4,290,518

(LGIM)

8.81%

ย 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

ย 

Legal & General Group Plc (Direct and Indirect) (Group) (4,290,518, 8.81% = Total Position)

Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect) (4,290,518, 8.81% = Total Position)

Legal & General Investment Management Limited (Indirect) (LGIM) (4,290,518, 8.81% = Total Position)

Legal & General (Unit Trust Managers) Limited (Below 5% = UTM)

Legal & General Group Plc (Direct) (L&G) (2,472,018, 5.07% = LGAS, LGPL & PMC)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD)

Legal & General Insurance Holdings Limited (Direct) (LGIH) (LGAS & LGPL)

Legal & General Assurance (Pensions Management) Limited (PMC)

Legal & General Assurance Society Limited (LGAS & LGPL) (LGAS & LGPL)

Legal & General Pensions Limited (Direct) (LGPL)

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

ย 

ย 

ย 

13. Additional information:

Notification using the total voting rights figure of ย 48,699,456

14. Contact name:

Victoria Davies (LGIM)

15. Contact telephone number:

029 2035 4147

ย 

This information is provided by RNS
The company news service from the London Stock Exchange
ย 
END
ย 
ย 
HOLBTBTTMBAMBFF
Date   Source Headline
14th Aug 20202:05 pmRNSSecond Price Monitoring Extn
14th Aug 20202:00 pmRNSPrice Monitoring Extension
14th Aug 20207:00 amRNSRegistration Statement Declared Effective
10th Aug 20205:36 pmRNSHolding(s) in Company
7th Aug 20207:00 amRNSHolding(s) in Company
6th Aug 20204:54 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHolding(s) in Company
3rd Aug 20203:00 pmRNSHolding(s) in Company
31st Jul 20202:48 pmRNSResult of AGM
30th Jul 202011:00 amRNSPrice Monitoring Extension
30th Jul 20207:00 amRNSHolding(s) in Company
29th Jul 20204:35 pmRNSHolding(s) in Company
27th Jul 20209:40 amRNSBroker Option Fully Exercised
27th Jul 20207:00 amRNSUK Placing to Raise £5.0 million
24th Jul 20201:31 pmRNSHolding(s) in Company
24th Jul 20208:43 amRNSForm 8.3 - Midatech Pharma PLC
23rd Jul 20202:41 pmRNSForm 8.3 - Midatech Pharma plc
23rd Jul 20207:00 amRNSCorporate Update & Formal Sale Process Termination
22nd Jul 20203:25 pmRNSForm 8.3 - Midatech Pharma plc
21st Jul 20202:05 pmRNSSecond Price Monitoring Extn
21st Jul 20202:00 pmRNSPrice Monitoring Extension
21st Jul 202011:05 amRNSSecond Price Monitoring Extn
21st Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20209:00 amRNSCollaboration for the Q-Sphera platform
3rd Jul 20205:48 pmRNSPosting of Annual Report & Notice of AGM
3rd Jul 20207:00 amBUSForm 8.3 - Midatech Pharma PLC
30th Jun 20201:37 pmRNSPublication of Annual Report
25th Jun 20203:10 pmRNSHolding(s) in Company
25th Jun 202012:01 pmRNSForm 8.3 - Midatech Pharma PLC
24th Jun 20205:18 pmBUSForm 8.3 - Midatech Pharma plc
24th Jun 202012:01 pmRNSForm 8.3 - Midatech Pharma PLC
18th Jun 20206:25 pmRNSForm 8 (DD) - Midatech Pharma plc
17th Jun 20207:00 amRNSGrant of Options
16th Jun 202010:20 amRNSInvestor Presentation
16th Jun 20207:00 amRNSResults for the year ended 31 December 2019
11th Jun 20203:41 pmRNSForm 8.3 - Midatech Pharma PLC
11th Jun 20203:35 pmRNSForm 8.3 - Midatech Pharma Plc
11th Jun 202010:53 amEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc (Replacement)
11th Jun 20207:00 amRNSHolding(s) in Company
11th Jun 20207:00 amRNSHolding(s) in Company
10th Jun 20202:00 pmRNSPrice Monitoring Extension
10th Jun 202012:57 pmRNSForm 8.3 - Midatech Pharma plc
10th Jun 202011:00 amRNSPrice Monitoring Extension
9th Jun 20205:35 pmRNSForm 8.3 - Midatech Pharma plc
9th Jun 20204:36 pmRNSPrice Monitoring Extension
9th Jun 20204:04 pmRNSPurported Termination of MTX110 Licence Agreement
9th Jun 20202:48 pmEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma PLC
9th Jun 202012:14 pmRNSForm 8.3 - Midatech Pharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.